Sandostatin 00078-0182
Generic: Octreotide Acetate
Product NDC
00078-0182- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 21, 1988
- Listing Expires
- December 31, 2026
- Application
- NDA019667
Need to source Sandostatin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Octreotide Acetate | 500 ug/mL |
Drug Class
Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]
Packaging Options(1)
10 AMPULE in 1 PACKAGE (0078-0182-01) / 1 mL in 1 AMPULE (0078-0182-61)